Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Minimum manufacturing costs, national prices and estimated global availability of new repurposed therapies for COVID-19

View ORCID ProfileJunzheng Wang, Jacob Levi, Leah Ellis, Andrew Hill
doi: https://doi.org/10.1101/2021.06.01.21258147
Junzheng Wang
1Faculty of Medicine, Imperial College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Junzheng Wang
Jacob Levi
2Department of Intensive Care, University College London Hospital, University College London Hospitals NHS Foundation Trust
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leah Ellis
1Faculty of Medicine, Imperial College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Hill
3Department of Pharmacology and Therapeutics, University of Liverpool
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: microhaart{at}aol.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Article usage

Article usage: June 2021 to May 2025

AbstractFullPdf
Jun 20214149223621
Jul 20211252478142
Aug 20212941839355
Sep 20211755796449
Oct 202117031122635
Nov 2021511568772
Dec 2021422462513
Jan 20224703221292
Feb 2022339217225
Mar 2022197179215
Apr 2022194157133
May 202215112885
Jun 20221219353
Jul 202214412096
Aug 20221339689
Sep 202212911859
Oct 202211410562
Nov 20226312268
Dec 20225813677
Jan 20237311843
Feb 20237712742
Mar 20233310232
Apr 20235208569
May 2023366253
Jun 2023275141
Jul 2023327345
Aug 20233511458
Sep 2023468540
Oct 20234411852
Nov 2023287259
Dec 2023319441
Jan 2024427878
Feb 20244812764
Mar 20244210850
Apr 20244012555
May 20244110249
Jun 2024709855
Jul 20245514453
Aug 20246312663
Sep 2024837260
Oct 20246810876
Nov 20247072128
Dec 20248113387
Jan 20259518185
Feb 202576379136
Mar 2025114312137
Apr 2025115532165
May 20254216760
Back to top
PreviousNext
Posted June 03, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Minimum manufacturing costs, national prices and estimated global availability of new repurposed therapies for COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Minimum manufacturing costs, national prices and estimated global availability of new repurposed therapies for COVID-19
Junzheng Wang, Jacob Levi, Leah Ellis, Andrew Hill
medRxiv 2021.06.01.21258147; doi: https://doi.org/10.1101/2021.06.01.21258147
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Minimum manufacturing costs, national prices and estimated global availability of new repurposed therapies for COVID-19
Junzheng Wang, Jacob Levi, Leah Ellis, Andrew Hill
medRxiv 2021.06.01.21258147; doi: https://doi.org/10.1101/2021.06.01.21258147

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Economics
Subject Areas
All Articles
  • Addiction Medicine (427)
  • Allergy and Immunology (753)
  • Anesthesia (220)
  • Cardiovascular Medicine (3281)
  • Dentistry and Oral Medicine (362)
  • Dermatology (274)
  • Emergency Medicine (478)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1164)
  • Epidemiology (13340)
  • Forensic Medicine (19)
  • Gastroenterology (897)
  • Genetic and Genomic Medicine (5130)
  • Geriatric Medicine (479)
  • Health Economics (781)
  • Health Informatics (3253)
  • Health Policy (1138)
  • Health Systems and Quality Improvement (1189)
  • Hematology (427)
  • HIV/AIDS (1014)
  • Infectious Diseases (except HIV/AIDS) (14613)
  • Intensive Care and Critical Care Medicine (910)
  • Medical Education (475)
  • Medical Ethics (126)
  • Nephrology (522)
  • Neurology (4901)
  • Nursing (261)
  • Nutrition (725)
  • Obstetrics and Gynecology (880)
  • Occupational and Environmental Health (795)
  • Oncology (2516)
  • Ophthalmology (722)
  • Orthopedics (280)
  • Otolaryngology (346)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (540)
  • Pediatrics (1298)
  • Pharmacology and Therapeutics (548)
  • Primary Care Research (554)
  • Psychiatry and Clinical Psychology (4193)
  • Public and Global Health (7482)
  • Radiology and Imaging (1702)
  • Rehabilitation Medicine and Physical Therapy (1010)
  • Respiratory Medicine (979)
  • Rheumatology (478)
  • Sexual and Reproductive Health (495)
  • Sports Medicine (424)
  • Surgery (546)
  • Toxicology (71)
  • Transplantation (235)
  • Urology (203)